Terms: = Bone cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Treatment
51 results:
1. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-abl1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract] [Full Text] [Related]
2. Myeloproliferative Neoplasm Driven by
Renzi S; Algawahmed F; Davidson S; Langenberg KPS; Fuligni F; Ali S; Anderson N; Brunga L; Bartram J; Abdelhaleem M; Naqvi A; Beimnet K; Schuh A; Tierens A; Malkin D; Shlien A; Shago M; Villani A
Curr Oncol; 2023 Jun; 30(7):5946-5952. PubMed ID: 37503586
[No Abstract] [Full Text] [Related]
3. Marginal resection as a potential curative treatment option of infantile fibrosarcoma with good response after chemotherapy: A case report of an etv6-NTRK3 positive infantile fibrosacroma of the distal tibia.
Weber M; von Kunow F; Hillmann A
Medicine (Baltimore); 2023 Jul; 102(27):e34194. PubMed ID: 37417635
[TBL] [Abstract] [Full Text] [Related]
4. The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Wang SA; Orazi A; Gotlib J; Reiter A; Tzankov A; Hasserjian RP; Arber DA; Tefferi A
Am J Hematol; 2023 Aug; 98(8):1286-1306. PubMed ID: 37283522
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
Zhang L; Shah B; Zhang Y; Tashkandi H; Xiao W; Fernandez-Pol S; Vergara-Lluri M; Hussaini M; Song J; Lancet J; Moscinski L; Yun S; Lu CM; Medeiros LJ; Tang G
Hum Pathol; 2023 Jun; 136():1-15. PubMed ID: 36958463
[TBL] [Abstract] [Full Text] [Related]
6. High frequency of heat shock protein 27 overexpression is a highly effective, high-coverage marker for minimal residual disease detection in children with B-cell acute lymphoblastic leukemia.
Chou SW; Su YH; Lu MY; Chang HH; Yang YL; Lin DT; Lin KH; Coustan-Smith E; Jou ST
Pediatr Blood Cancer; 2023 Jan; 70(1):e29990. PubMed ID: 36250996
[TBL] [Abstract] [Full Text] [Related]
7. etv6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.
Fishman H; Madiwale S; Geron I; Bari V; Van Loocke W; Kirschenbaum Y; Ganmore I; Kugler E; Rein-Gil A; Friedlander G; Schiby G; Birger Y; Strehl S; Soulier J; Knoechel B; Ferrando A; Noy-Lotan S; Nagler A; Mulloy JC; Van Vlierberghe P; Izraeli S
Blood; 2022 Jan; 139(3):399-412. PubMed ID: 34624096
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry.
Shouval R; Fein JA; Labopin M; Cho C; Bazarbachi A; Baron F; Bug G; Ciceri F; Corbacioglu S; Galimard JE; Giebel S; Gilleece MH; Giralt S; Jakubowski A; Montoto S; O'Reilly RJ; Papadopoulos EB; Peric Z; Ruggeri A; Sanz J; Sauter CS; Savani BN; Schmid C; Spyridonidis A; Tamari R; Versluis J; Yakoub-Agha I; Perales MA; Mohty M; Nagler A
Lancet Haematol; 2021 Mar; 8(3):e205-e215. PubMed ID: 33636142
[TBL] [Abstract] [Full Text] [Related]
9. Surgically Treated Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: Outcome Predictors and the Role of Adjuvant Radiation Therapy.
Kampel L; Dorman A; Horowitz G; Fliss DM; Gutfeld O; Muhanna N
Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1016-1023. PubMed ID: 33514267
[TBL] [Abstract] [Full Text] [Related]
10. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
[TBL] [Abstract] [Full Text] [Related]
11. Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in etv6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.
Mehtonen J; Teppo S; Lahnalampi M; Kokko A; Kaukonen R; Oksa L; Bouvy-Liivrand M; Malyukova A; Mäkinen A; Laukkanen S; Mäkinen PI; Rounioja S; Ruusuvuori P; Sangfelt O; Lund R; Lönnberg T; Lohi O; Heinäniemi M
Genome Med; 2020 Nov; 12(1):99. PubMed ID: 33218352
[TBL] [Abstract] [Full Text] [Related]
12. [Sinonasal renal cell-like adenocarcinoma: a clinicopathological analysis of five cases].
Yuan CC; Zhai CW; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1147-1151. PubMed ID: 33152820
[No Abstract] [Full Text] [Related]
13. Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome.
Laurent AP; Kotecha RS; Malinge S
Leukemia; 2020 Aug; 34(8):1984-1999. PubMed ID: 32433508
[TBL] [Abstract] [Full Text] [Related]
14. Chronic myelomonocytic leukemia with etv6-abl1 rearrangement and SMC1A mutation.
Cessna MH; Paulraj P; Hilton B; Sadre-Bazzaz K; Szankasi P; Cluff A; Patel JL; Hoda D; Toydemir RM
Cancer Genet; 2019 Oct; 238():31-36. PubMed ID: 31425923
[TBL] [Abstract] [Full Text] [Related]
15. A Case of Papillary Thyroid Carcinoma and Kostmann Syndrome: A Genomic Theranostic Approach for Comprehensive treatment.
Han S; Ehrhardt J; Shukla S; Elkbuli A; Nikiforov YE; Gulec SA
Am J Case Rep; 2019 Jul; 20():1027-1034. PubMed ID: 31308356
[TBL] [Abstract] [Full Text] [Related]
16. Surgical outcomes after reoperation for recurrent skull base meningiomas.
Magill ST; Lee DS; Yen AJ; Lucas CG; Raleigh DR; Aghi MK; Theodosopoulos PV; McDermott MW
J Neurosurg; 2018 May; 130(3):876-883. PubMed ID: 29726777
[TBL] [Abstract] [Full Text] [Related]
17. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract] [Full Text] [Related]
18. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia.
Sędek Ł; Theunissen P; Sobral da Costa E; van der Sluijs-Gelling A; Mejstrikova E; Gaipa G; Sonsala A; Twardoch M; Oliveira E; Novakova M; Buracchi C; van Dongen JJM; Orfao A; van der Velden VHJ; Szczepański T;
J Immunol Methods; 2019 Dec; 475():112429. PubMed ID: 29530508
[TBL] [Abstract] [Full Text] [Related]
19. Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in
Smith KM; Fagan PC; Pomari E; Germano G; Frasson C; Walsh C; Silverman I; Bonvini P; Li G
Mol Cancer Ther; 2018 Feb; 17(2):455-463. PubMed ID: 29237803
[TBL] [Abstract] [Full Text] [Related]
20. Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
Rauh LA; Pannone AF; Cantrell LA
Gynecol Oncol; 2017 Dec; 147(3):597-600. PubMed ID: 28923411
[TBL] [Abstract] [Full Text] [Related]
[Next]
